Association of Neurofilament Light Chain With the Antidepressant Effects of Low-Dose Ketamine Infusion Among Patients With Treatment-Resistant Depression

被引:2
|
作者
Lin, Wei-Chen [1 ,2 ,4 ]
Su, Tung-Ping [1 ,2 ,3 ,4 ,5 ]
Li, Cheng-Ta [1 ,4 ]
Wu, Hui-Ju [1 ]
Bai, Ya-Mei [1 ,2 ,4 ]
Liu, Yu-Li [6 ]
Tu, Pei-Chi [1 ,2 ,3 ]
Chen, Mu-Hong [1 ,2 ,4 ,7 ]
机构
[1] Taipei Vet Gen Hosp, Dept Psychiat, Taipei, Taiwan
[2] Natl Yang Ming Chiao Tung Univ, Fac Med, Div Psychiat, Taipei, Taiwan
[3] Taipei Vet Gen Hosp, Dept Med Res, Taipei, Taiwan
[4] Natl Yang Ming Chiao Tung Univ, Inst Brain Sci, Taipei, Taiwan
[5] Cheng Hsin Gen Hosp, Dept Psychiat, Taipei, Taiwan
[6] Natl Hlth Res Inst, Ctr Neuropsychiat Res, Zhunan, Taiwan
[7] Taipei Vet Gen Hosp, Dept Psychiat, 201 Sec2,Shih-Pai Rd, Taipei 112, Taiwan
来源
关键词
Neurofilament light chain; ketamine; treatment-resistant depression; Taiwan; NEUROAXONAL INTEGRITY; BIOMARKER;
D O I
10.1093/ijnp/pyad045
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: The role of neurofilament light chain (NFL) in treatment-resistant depression (TRD) is unclear. Whether baseline NFL concentrations are associated with the antidepressant effects of low-dose ketamine infusion has not been determined.Methods: The NFL concentrations of 71 patients with TRD and 17 healthy controls were assessed. Patients with TRD were randomly administered a single infusion of 0.5 mg/kg ketamine, 0.2 mg/kg ketamine, or normal saline. Depressive symptoms were assessed before infusion and sequentially at postinfusion timepoints (after 240 minutes and after 2-7 and 14 days) using the Hamilton Depression Rating Scale (HDRS).Results: After adjustment for age, sex, and body mass index, patients with TRD were more likely to have higher concentrations of NFL than healthy controls (P < .001). A generalized estimating equation model with adjustments for infusion group, age, sex, body mass index, and baseline HDRS scores showed that baseline NFL concentrations were positively associated with subsequent HDRS scores following low-dose ketamine infusion (P = .038).Discussion: Higher concentrations of NFL were observed among patients with TRD compared with healthy controls. Baseline NFL concentrations may predict the antidepressant effects of low-dose ketamine infusion.
引用
收藏
页码:649 / 653
页数:5
相关论文
共 50 条
  • [41] Cytokine- and Vascular Endothelial Growth Factor-Related Gene-Based Genome-Wide Association Study of Low-Dose Ketamine Infusion in Patients with Treatment-Resistant Depression
    Tsai, Shih-Jen
    Kao, Chung-Feng
    Su, Tung-Ping
    Li, Cheng-Ta
    Lin, Wei-Chen
    Hong, Chen-Jee
    Bai, Ya-Mei
    Tu, Pei-Chi
    Chen, Mu-Hong
    [J]. CNS DRUGS, 2023, 37 (03) : 243 - 253
  • [42] Treatment-resistant depression - Response to low-dose transdermal but not oral selegiline
    Morgan, Peter T.
    [J]. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2007, 27 (03) : 313 - 314
  • [43] Antisuicidal effect, BDNF Val66Met polymorphism, and low-dose ketamine infusion: Reanalysis of adjunctive ketamine study of Taiwanese patients with treatment-resistant depression (AKSTP-TRD)
    Chen, Mu-Hong
    Lin, Wei-Chen
    Wu, Hui-Ju
    Cheng, Chih-Ming
    Li, Cheng-Ta
    Hong, Chen-Jee
    Tu, Pei-Chi
    Bai, Ya-Mei
    Tsai, Shih-Jen
    Su, Tung-Ping
    [J]. JOURNAL OF AFFECTIVE DISORDERS, 2019, 251 : 162 - 169
  • [44] Antidepressant effects of dexmedetomidine compared with ECT in patients with treatment-resistant depression
    Liu, Yusi
    Hu, Qiyun
    Xu, Sen
    Li, Wanwen
    Liu, Junyun
    Han, Liang
    Mao, Hui
    Cai, Fang
    Liu, Qiaoyan
    Zhu, Renlai
    Fang, Caiyun
    Lou, Yifei
    Wang, Zhenhua
    Yang, Huiling
    Wang, Wenyuan
    [J]. JOURNAL OF AFFECTIVE DISORDERS, 2024, 347 : 437 - 444
  • [45] Efficacy of low-dose isotretinoin in patients with treatment-resistant rosacea
    Erdogan, FG
    Yurtsever, P
    Aksoy, D
    Eskioglu, F
    [J]. ARCHIVES OF DERMATOLOGY, 1998, 134 (07) : 884 - 885
  • [46] Cognitive Behavior Therapy May Sustain Antidepressant Effects of Intravenous Ketamine in Treatment-Resistant Depression
    Wilkinson, Samuel T.
    Wright, DaShaun
    Fasula, Madonna K.
    Fenton, Lisa
    Griepp, Matthew
    Ostroff, Robert B.
    Sanacora, Gerard
    [J]. PSYCHOTHERAPY AND PSYCHOSOMATICS, 2017, 86 (03) : 162 - 167
  • [47] Repeated Administrations of Ketamine in Treatment-Resistant Major Depression: Rapid Antidepressant Effects and Durability of Response
    Murrough, James W.
    Perez, Andrew M.
    Pillemer, Sarah
    Stem, Jessica
    Lapidus, Kyle
    Soleimani, Laili
    Alves, Diogo K.
    Charney, Dennis S.
    Iosifescu, Dan V.
    [J]. BIOLOGICAL PSYCHIATRY, 2012, 71 (08) : 60S - 60S
  • [48] Low-dose ketamine for treatment resistant depression in an academic clinical practice setting
    Feifel, David
    Malcolm, Benjamin
    Boggie, Danielle
    Lee, Kelly
    [J]. JOURNAL OF AFFECTIVE DISORDERS, 2017, 221 : 283 - 288
  • [49] Maintenance of antidepressant effect by dextromethorphan in patients with treatment-resistant depression who respond to ketamine intervention
    Chen, Mu-Hong
    Tsai, Shih-Jen
    [J]. MEDICAL HYPOTHESES, 2024, 182
  • [50] Use of Ketamine in Elderly Patients with Treatment-Resistant Depression
    Ribeiro, Carolina Medeiros da Frota
    Riva-Posse, Patricio
    [J]. CURRENT PSYCHIATRY REPORTS, 2017, 19 (12)